TABLE 5.
Impact of catheter duration of the adverse event profile
| ≤3 days (n = 1853), n (%) | >3 days (n = 2638), n (%) | P value | |
|---|---|---|---|
| At least one adverse event during catheter period | 281 (19.7) | 1453 (33.8) | <0.001 |
| Haematuria | 177 (9.6) | 274 (10.4) | 0.35 |
| Asymptomatic bacteriuria | 81 (5.7) | 579 (13.5) | <0.001 |
| Lower urinary tract infection | 49 (3.4) | 308 (7.2) | <0.001 |
| Urosepsis | 9 (0.6) | 51 (1.2) | 0.06 |
| Urine leak | 52 (3.7) | 297 (6.9) | <0.001 |
| Catheter obstruction | 12 (0.8) | 133 (3.1) | <0.001 |
| Other adverse events | 14 (1.0) | 72 (1.7) | 0.05 |
| Prolongation of hospitalization for adverse event | 47 (3.5) | 209 (5.2) | 0.007 |